维普期刊资源整合服务平台（V6.5）

75篇 您的检索式：作者名="Bowden C R"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Clinical,cellular*and molecular factors that contribute to antifungal drugresisitance显示文摘	White T C’Marr K A Bowden R A	1998	Clin Mierobiol Rev1998，11，：	1
2	Independent review of E2100:a phase Ⅲ trial of bevacizumab plus paclitaxel versus paclitaxel in women with metastatic breast cancer显示文摘	GRAY R BHATTACHARYA S BOWDEN C	2009	J Clin Oncol2009，27，30：	1
3	Tech- niques of PIV in stratified two-phase headers显示文摘	SALEH W BOWDEN R C HASSAN I G	2010	Experi- mental Thermal and Fluid Science2010，35，1：	1
4	The efficacy of lamotrigine in rapid cycling and non-rapid cycling with bipolar disorder显示文摘	BOWDEN C L CALABRASE J R MCELROY S L	1999	Biol Psychiatry1999，45，：	1
5	Classical-quantum correspondence for multilevel systems 显示文摘	Bowden C M Narducci L M	1975	Phys Rev A1975，12，3：	1
6	Independent review of E2100: a phase Ⅲ trial of bevacizumab plus paclitaxel versus paclitaxel in women with metastatic breast cancer显示文摘	Gray R Bhattacharya S Bowden C	2009	J Clin Oncol2009，27，30：	1
7	Independent review of E2100:a phas e III trial of bevacizumab plus paclitaxel versus paclitaxel i n women with metastatic breast cancer显示文摘	Gray R Bhattach arya S Bowden C		0，，30：	1
8	A placebo controlled 18-monthtrial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with biplor Ⅰ disorder显示文摘	BOWDEN C L CALABRASE J R SACHS G	2003	Arch Gen psychiatry2003，60，：	1
9	Independent review of E2100; a phase III reial of bevacizumab puls paclitaxel versuspaclitaxel in metastatic breast cancer显示文摘	Gray R Bhattacharya S Bowden C	2009	J Clin Oncol2009，27，30：	1
10	Fuel partitioning and food intake:Role for mitochondrial fatty acid transport显示文摘	Friedman M I Ramirez I Bowden C R		0，，：	1
11	Synthesis,characterization,and anorectic testing of the four stereoisomers of cyclo(histidylproline)显示文摘	Breslin H J Bowden C R	1985	J Med Chem1985，28，11：	1
12	Clinical, cellular, and molecular factors that contribute to antifungal drug resistance显示文摘	White T C Marr K A Bowden R A	1998	Clin Microbiol Rev1998，11，：	1
13	Cultivar mixtures for the simultaneous management of multiple disease显示文摘	Cox C M Garrett K A Bowden R L	2004	Phytopathology2004，94，：	1
14	Independent review of E2100: A phase Ⅲ trial of bevacizumab plus paclitaxel versus paclitaxel in women with metastatic breast cancer 显示文摘	Gray R Bhattacharya S Bowden C	2009	J Clin Oncol2009，27，30：	1
15	Independent review of E2100:a phase II trial of bevacizumab plus paclitaxel versus paclitaxe1 in women with metastatic breast cancer显示文摘	Gray R Bhattacharya S Bowden C	2009	1 Clin Oncol2009，27，：	1
16	Lack of association be- tween cerato-ulmin production and virulence in Ophiostoma novul- mi 显示文摘	Bowden C G Smalley E Guries R P	1996	Molecular Plant-Microbe Interactions1996，9，7：	1
17	Effects of ribose supplementation prior to and during intense exercise on anaerobic capacity and metabolic markers 显示文摘	Rasmussen C Bowden R Leutholtz B	2005	Int J Sport Nutr Exerc Metab2005，15，6：	1
18	Clinical cellular and molecular factors that contribute to antifungal drug resistance 显示文摘	White T C Marrk A Bowden R A	1998	Clin MicrobiolRev1998，11，2：	1
19	Clinical, cellular, and molecular factors that contribute to antifungal drug resistance 显示文摘	White T C Marr K A Bowden R A	1998	Clin Microbiol Rev1998，11，4：	1
20	Clinical,cellular,and molecular factors that contribute to antifungal drug resistance显示文摘	White T C Marr K A Bowden R A	1998	Clin Microbiol Rev1998，11，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示